Charles Schwab Investment Management Inc Immunic, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 25,000 shares of IMUX stock, worth $25,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,100
0.4%
Holding current value
$25,000
Previous $27,000
51.85%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IMUX
# of Institutions
70Shares Held
56.2MCall Options Held
100Put Options Held
350K-
Bvf Inc San Francisco, CA8.9MShares$8.9 Million0.47% of portfolio
-
Avidity Partners Management LP Dallas, TX8.27MShares$8.27 Million0.84% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.29 Million1.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$5.59 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X05.1MShares$5.1 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $30.6M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...